NEW

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

Encompass Group- FusionTM Patient Care Underpads by MIP

Maintaining skin integrity is a critical component in the care of the hospitalized patient. Understanding the impact of methods to maintain skin integrity is vital toward the prevention of pressure ulcers and skin breakdown. The use of a new technology synthetic reusable underpad is beneficial to the patient in the acute care setting because of its ability to promote skin integrity – not just protect the bed linen. Encompass Group LLC offers a full line of synthetic underpads, all with the goal of providing enhanced protection for the patient. The FusionTM underpad is in addition to the clinically proven DermaCareTM underpad. This technologically advanced reusable underpad is intended to provide the ultimate in patient comfort and care. For more information, visit www.encompassgroup.net.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X